SPIRONOLACTONE TEVA 25 mg, film-coated tablet scored 30 tablets
Active ingredients: Spironolactone
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SPIRONOLACTONE TEVA 25 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 30 comprimé(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 18 Dec 2009
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64802027CIP73959884CIP133400939598840Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SPIRONOLACTONEcomprimé | 25 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.